Literature DB >> 23167828

Cause-specific mortality among patients with epilepsy: results from a 30-year cohort study.

Eugen Trinka1, Gerhard Bauer, Willi Oberaigner, Jean-Pierre Ndayisaba, Klaus Seppi, Claudia A Granbichler.   

Abstract

PURPOSE: Death rates of patients with epilepsy are two to three times higher than expected. The aim of our study was to further delineate the causes and the patterns of premature death in patients with epilepsy.
METHODS: We included all patients who were prospectively enrolled between 1970 and 1999 in our epilepsy outpatient clinical database. Patients were followed until death or December 31, 2003. Standardized mortality ratios (SMRs) were calculated using reference rates from the same region. KEY
FINDINGS: After 48,595 person years of follow-up, 648 of 3,334 patients had died, resulting in an overall SMR of 2.2 (95% confidence interval [CI] 2.0-2.4). The highest SMRs were for patients aged 26-45 years (6.8, 95% CI 3.8-11.2) and with symptomatic epilepsies (3.1, 95% CI 2.3-4.9); those for cryptogenic causes (2.2, 95% CI 1.6-3.1) were also elevated, whereas those for idiopathic causes were not increased (2.7, 95% CI 0.7-7.0) after 2 years of follow-up. SMRs for patients with persistent seizures (3.3, 95% CI 2.6-4.4) were higher than those for seizure-free patients (1.4, 95% CI 0.8-2.3). The highest cause-specific SMRs were for epilepsy (91.6, 95% CI 66.3-123.4), brain tumors (22.7, 95% CI 15.7-31.8), and external causes (2.4, 95% CI 1.8-3.3) at end of study period. SIGNIFICANCE: Epilepsy patients have a higher-than-expected risk of death throughout life and especially during the first 2 years following diagnosis. Standardized mortality rates were especially high in younger patients and in patients with symptomatic epilepsies. Persistent seizures are strongly related to excess mortality. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2012        PMID: 23167828     DOI: 10.1111/epi.12014

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  21 in total

Review 1.  The burden of premature mortality of epilepsy in high-income countries: A systematic review from the Mortality Task Force of the International League Against Epilepsy.

Authors:  David J Thurman; Giancarlo Logroscino; Ettore Beghi; W Allen Hauser; Dale C Hesdorffer; Charles R Newton; Fulvio Alexandre Scorza; Josemir W Sander; Torbjörn Tomson
Journal:  Epilepsia       Date:  2016-11-26       Impact factor: 5.864

2.  Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study.

Authors:  Olli Nevalainen; Jani Raitanen; Hanna Ansakorpi; Miia Artama; Jouko Isojärvi; Anssi Auvinen
Journal:  Eur J Epidemiol       Date:  2013-09-26       Impact factor: 8.082

3.  Multimorbidity and chronic co-prescription networks and potential interactions in adult patients with epilepsy: MorbiNet study.

Authors:  Ferran Moratalla-Navarro; Victor Moreno; Flora López-Simarro; Maria Estrella Barceló; Alba Aguado
Journal:  Neurol Sci       Date:  2022-09-05       Impact factor: 3.830

4.  The Prevention and Reversal of a Phenytoin-Resistant Model by N-acetylcysteine Therapy Involves the Nrf2/P-Glycoprotein Pathway at the Blood-Brain Barrier.

Authors:  Qiankun Liu; You Wang; Dandan Tan; Yong Liu; Peng Zhang; Limin Ma; Minxue Liang; Yangmei Chen
Journal:  J Mol Neurosci       Date:  2022-08-26       Impact factor: 2.866

5.  Benefits from Exclusion Treatment of Unruptured Brain Arteriovenous Malformations on Epilepsy in Adults.

Authors:  Romain Capocci; Michaela Bustuchina Vlaicu; Eimad Shotar; Bertrand Mathon; Mariette Delaitre; Kévin Premat; Maichael Talaat; Atika Talbi; Anne-Laure Boch; Stéphanie Lenck; Alexandre Carpentier; Vincent Degos; Nader Antoine Sourour; Frédéric Clarençon
Journal:  Clin Neuroradiol       Date:  2021-11-22       Impact factor: 3.156

6.  Premature mortality in poor health and low income adults with epilepsy.

Authors:  Kitti Kaiboriboon; Nicholas K Schiltz; Paul M Bakaki; Samden D Lhatoo; Siran M Koroukian
Journal:  Epilepsia       Date:  2014-09-19       Impact factor: 5.864

Review 7.  Epilepsy, excess deaths and years of life lost from external causes.

Authors:  Olli Nevalainen; Mikko Simola; Hanna Ansakorpi; Jani Raitanen; Miia Artama; Jouko Isojärvi; Anssi Auvinen
Journal:  Eur J Epidemiol       Date:  2015-10-31       Impact factor: 8.082

8.  Adjunctive Cannabidiol in Patients with Dravet Syndrome: A Systematic Review and Meta-Analysis of Efficacy and Safety.

Authors:  Simona Lattanzi; Francesco Brigo; Eugen Trinka; Gaetano Zaccara; Pasquale Striano; Cinzia Del Giovane; Mauro Silvestrini
Journal:  CNS Drugs       Date:  2020-03       Impact factor: 5.749

9.  Risk of Unnatural Mortality in People With Epilepsy.

Authors:  Hayley C Gorton; Roger T Webb; Matthew J Carr; Marcos DelPozo-Banos; Ann John; Darren M Ashcroft
Journal:  JAMA Neurol       Date:  2018-08-01       Impact factor: 18.302

10.  Epoxy fatty acids and inhibition of the soluble epoxide hydrolase selectively modulate GABA mediated neurotransmission to delay onset of seizures.

Authors:  Bora Inceoglu; Dorota Zolkowska; Hyun Ju Yoo; Karen M Wagner; Jun Yang; Edward Hackett; Sung Hee Hwang; Kin Sing Stephen Lee; Michael A Rogawski; Christophe Morisseau; Bruce D Hammock
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.